Sigma-Aldrich Given Consensus Rating of “Hold” by Brokerages (NASDAQ:SIAL)
Shares of Sigma-Aldrich (NASDAQ:SIAL) have earned an average recommendation of “Hold” from the ten analysts that are presently covering the company, Stock Ratings Network reports. Two investment analysts have rated the stock with a sell recommendation, seven have issued a hold recommendation and one has given a buy recommendation to the company. The average 12-month target price among brokers that have issued a report on the stock in the last year is $92.33.
Sigma-Aldrich (NASDAQ:SIAL) opened at 104.00 on Wednesday. Sigma-Aldrich has a one year low of $82.03 and a one year high of $104.32. The stock has a 50-day moving average of $102. and a 200-day moving average of $98.04. The company has a market cap of $12.373 billion and a price-to-earnings ratio of 24.52.
Sigma-Aldrich (NASDAQ:SIAL) last issued its quarterly earnings data on Thursday, July 24th. The company reported $1.11 earnings per share for the quarter, meeting the analysts’ consensus estimate of $1.11. The company had revenue of $701.00 million for the quarter, compared to the consensus estimate of $706.14 million. During the same quarter last year, the company posted $1.05 earnings per share. Sigma-Aldrich’s revenue was up 2.9% compared to the same quarter last year. Analysts expect that Sigma-Aldrich will post $4.36 EPS for the current fiscal year.
SIAL has been the subject of a number of recent research reports. Analysts at Zacks reiterated a “neutral” rating on shares of Sigma-Aldrich in a research note on Tuesday, August 12th. They now have a $107.00 price target on the stock. Separately, analysts at JPMorgan Chase & Co. reiterated a “neutral” rating on shares of Sigma-Aldrich in a research note on Friday, July 25th. They now have a $97.00 price target on the stock, up previously from $95.00. Finally, analysts at Citigroup Inc. initiated coverage on shares of Sigma-Aldrich in a research note on Thursday, July 17th. They set a “neutral” rating and a $107.00 price target on the stock.
Sigma-Aldrich Corporation is a life science and high technology company. The Company develops, manufactures, purchases and distributes the range of chemicals, biochemicals and equipment available globally and also provides global biopharmaceutical testing services.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.